Hampshire Hospitals NHS Foundation Trust Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2011
NCT01068353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hampshire Hospitals NHS Foundation Trust

Active Ingredients

Drugs in Phase 2 Trials (1)

etanercept (enbrel) (1 trial)

Drugs in Phase 1 Trials (1)

povidone-iodine (betadine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Coronavirus Infections (Phase 1)

Severe Acute Respiratory Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2